Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

Share Price is delayed by 15 minutes
Get Live Data
74.60    0.30 (0.40%)
Bid:
74.90
Ask:
75.20
Spread: 0.30 (0.401%)
Market Cap: £358.81m
CHRY Live PriceLast checked at - London Stock Exchange

Intraday Chrysalis Inves Share Chart

Interim NAV Announcement

14 Apr 2022 07:00

RNS Number : 3386I
Chrysalis Investments Limited
14 April 2022
 

 

 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of South Africa.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which forms part of domestic law in the United Kingdom pursuant to The European Union Withdrawal Act 2018, as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019.

 

14 April 2022

 

 

Chrysalis Investments Limited (the "Company")

 

Interim NAV Announcement

 

 

In view of market movements and volatility since the 31st December 2021, the Board considered it appropriate to release an unaudited interim Net Asset Value (the "Interim NAV"). This decision was influenced by the current extraordinary geopolitical events, which have exacerbated recent macroeconomic uncertainty, and have led to some instances of material share price fluctuations of relevant listed peers to the Company's portfolio assets.

 

To this end, the Company commissioned an independent third party to value, as at 21 March 2022, 6 assets (representing together with cash and listed assets approximately 67% of the Company's gross portfolio value at 31st December 2021). The remaining 33% of the Company's assets have been revalued using a valuation methodology comparable to that applied at 31 December 2021.

 

The Interim NAV is intended for guidance purposes only and the Company will issue its formal NAV calculation as of 31 March 2022 in due course, in line with its normal business practices.

 

The Company announces that as of 21 March 2022, the Interim NAV per ordinary share was approximately 208 pence, which represents an approximate 13% decrease since 31 December 2021.

 

The above Interim NAV calculation is based upon the Company's issued share capital as of 21 March 2022 of 595,150,415 shares.

 

Within the Interim NAV, the listed portion of the portfolio accounts for approximately 7% of gross portfolio value, with cash accounting for approximately a further 6%.

 

 

-ENDS-

 

For further information, please contact:

 

Jupiter Asset Management:

James Simpson

 

 

 

+44 (0) 20 3817 1696

 

Liberum:

Chris Clarke /Darren Vickers / Owen Matthews

 

+44 (0) 20 3100 2000

Numis Securities Limited:

Nathan Brown / Matt Goss

 

+44 (0) 20 7260 1000

Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier

 

+44 (0) 1481 749364

 

 

Media Enquiries:

 

Montfort Communications

Charlotte McMullen

 

 

+44 (0) 20 3514 0897

Chrysalis@montfort.london

LEI: 213800F9SQ753JQHSW24

 

A copy of this announcement will be available on the Company's website at http://chrysalisinvestments.co.uk. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

 

This announcement may include "forward-looking statements". All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Company's products and services) are forward-looking statements.

 

Forward-looking statements are subject to risks and uncertainties and accordingly the Company's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These factors include but are not limited to those described in the formal Prospectus. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules or Prospectus Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBKNBPOBKDDQD
Date   Source Headline
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20262:58 pmRNSBoard clarification in response to stmt by CIP
20th Feb 20267:02 amRNSTransaction in Own Shares
20th Feb 20267:01 amRNSPropose New Inv Policy New Mgmt Arr. Notice of EGM
20th Feb 20267:00 amRNSAppointment of Director
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 202612:30 pmRNSHolding(s) in Company
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:01 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSQuarterly NAV Announcement and Trading Update
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20262:43 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.